Background
Right ventricular function is associated with long-term outcomes of heart failure (HF), particularly with atrial fibrillation (AF). The aim of this study was to evaluate the prognostic value of Doppler tissue imaging at the mitral and tricuspid annuli in patients with HF and AF.
Methods
In this prospective observational study, 457 patients (mean age, 67 years; 283 men) referred for HF with AF were enrolled and underwent conventional echocardiography including pulsed-wave Doppler tissue imaging. Systolic (s′) and early diastolic (e′) velocities of the tricuspid and mitral annuli were recorded from the apical four-chamber view. The development of clinical adverse events during the follow-up period was defined as the composite of cardiac death and readmission for HF.
Results
During the follow-up period (median, 20 months), 37 patients reached the primary end point (nine deaths and 28 cases of HF). Patients with cardiac events were significantly older and more often had previous HF admissions and diuretic use, higher New York Heart Association classes, and greater average ratios of peak early diastolic mitral inflow to annular velocity. Additionally, Doppler tissue imaging of s′ and e′ at the tricuspid, septal, and lateral mitral annuli were all reduced. Multivariate analysis showed that tricuspid s′ and septal e′ remained significant predictors of cardiac events. By Kaplan-Meier analysis, the occurrence of cardiac events was more frequent when tricuspid s′ was <9.0 cm/sec ( P < .001) and when septal e′ was <7.3 cm/sec ( P < .001).
Conclusions
In patients with HF and AF with a high risk for cardiac events, tricuspid s′ and septal e′ can be independent risk predictors of outcomes.
The assessment of prognosis in patients with atrial fibrillation (AF) has been performed in the clinical course of heart failure (HF). AF is believed to share pathophysiologic associations with hypertension and HF, although no definite etiology has been determined. Regarding the outcomes of HF, the concomitant presence of AF could be used to identify high-risk patients to prevent subsequent hospital admissions. In patients with AF, left ventricular (LV) diastolic or systolic dysfunction is frequently encountered, leading to left atrial (LA) enlargement and pressure elevation. The electromechanical features of AF may impair ventricular filling and cause irregular contraction with poor ventricular rate control, resulting in a cardiomyopathy that is common in the left ventricle but may also be seen in right ventricle. Consequently, AF commonly has adverse hemodynamic effects on both the left and right ventricles, causing right ventricular (RV) dysfunction or HF.
RV function is also considered to be an independent predictor of clinical events in HF, irrespective of LV functional severity. Furthermore, Doppler tissue imaging (DTI) of the tricuspid valve (TV) annulus has been found to provide information about RV longitudinal function in previous studies. Interestingly, systolic myocardial velocity as determined from the TV annulus could be a significant predictor of RV function and has proven to be a useful index in the prognosis of RV infarction. However, few studies in the literature have examined DTI of the TV annulus in patients with HF with AF, although DTI is easily used for LV evaluation. In addition, patients with nonsinus rhythms such as AF have been usually excluded from echocardiographic studies. Despite the prognostic significance of AF in terms of HF, AF has not shown a consistent impact for prognosis in patients with HF, but rather, its impact might be dependent on the severity of HF. Importantly, the association of TV DTI with AF has not been evaluated or focused in studies of HF. Therefore, we hypothesized that TV DTI would be as important as mitral valve (MV) DTI for clinical outcomes, particularly in the setting of clinical AF. The goals of the present study were to quantify RV dysfunction and to assess the relationship between TV DTI and the prognosis of HF with AF compared with MV DTI.
Methods
Study Population
This was a prospective observational study of consecutive patients with AF who were referred to our echocardiography laboratory between June 2008 and December 2009 for cardiac evaluation for symptoms or signs of HF in this study. At the time of enrollment, all patients who were clinically stable underwent transthoracic echocardiography. Patients aged ≥ 18 years were eligible for inclusion if they showed chronic permanent AF and symptomatic HF with New York Heart Association (NYHA) functional classes II to IV. Permanent AF was defined as AF that was refractory to cardioversion and did not convert to sinus rhythm for a period > 6 months. HF was defined according to the criteria of the European Society of Cardiology. The exclusion criteria were paroxysmal or persistent AF; acute coronary syndromes or coronary revascularization within the past 3 months; significant valvular heart disease (moderate or severe grade) or prosthetic valve replacement; advanced liver, renal, and lung disease; and congenital heart disease. Blood samples were obtained at enrollment for measurement of routine blood chemistry, including hemoglobin and renal functional parameters. Baseline, clinical, and echocardiographic data were recorded. The study protocol was approved by the hospital’s institutional review boards, and written informed consent was obtained from all patients.
Echocardiography
Echocardiographic examinations were performed using the cardiac ultrasound machine Vivid 7 with a 3.5-MHz transducer (GE Vingmed Ultrasound AS, Horten, Norway). Images were taken while patients were in the left lateral decubitus position. Conventional echocardiographic studies including DTI were performed according to the recommendations of the American Society of Echocardiography. LV end-systolic and end-diastolic dimensions, interventricular septal and posterior wall thicknesses, and LA anteroposterior diameter were determined from two-dimensional imaging. Ejection fraction (EF) was calculated using the biplane Simpson’s method. Additionally, LA volume was obtained using the formula for the biplane area-length method. Mitral inflow was recorded on apical four-chamber view, and its peak early velocity and deceleration time were measured. Pulsed-wave tissue Doppler recordings were obtained in the apical four-chamber view, and a sample volume of pulsed-wave Doppler was positioned on the lateral and septal sides of the MV annulus. In addition, tissue Doppler was also performed by placing the sample volume at the lateral side of the TV annulus. Care was taken to ensure that the Doppler beam was aligned parallel to the LV lateral and septal and RV lateral walls. We tried to obtain high–frame rate images, and gain settings were adjusted to avoid background noise and to obtain clear DTI tracings. From the spectral signals of both MV and TV annuli, we measured the peak systolic (s′) and early diastolic (e′) mitral (at both septal and lateral sides) and tricuspid annular velocities ( Figure 1 ). A mean of five consecutive beats were measured for all Doppler measurements at a sweep speed of 50 mm/sec, and all values were averaged.
Study Follow-Up
With regard to the adverse clinical outcomes of HF with AF, patients were followed up in the outpatient clinic as well as by telephone. The clinical primary end point was a composite of cardiac death and worsening HF requiring hospitalization.
Statistic Analysis
Data analyses were performed using SPSS for Windows version 12.0 (SPSS, Inc., Chicago, IL). All values are presented as mean ± SD for continuous variables and as frequencies for discrete variables. Categorical variables were analyzed using χ 2 tests and continuous variables using Student’s t tests. Receiver operating characteristic curves and the areas under the curves were obtained to compare the predictive value of echocardiographic parameters. Univariate and multivariate Cox proportional regression analysis was performed, and cumulative survival curves were constituted using the Kaplan-Meier method. The log-rank test was used to evaluate event-free survival according to the cutoff value for DTI. To address the independent contribution of DTI and to determine the incremental prognostic value over conventional data, a sequential Cox model analysis was performed, and a global χ 2 value was obtained. Two-sided P values < .05 were considered statistically significant.
Results
Baseline Clinical Characteristics of Study Patients
In our cohort study, a total of 534 patients with HF and AF were evaluated, and among those patients, we excluded 77 patients (13.4%) because of missing data and poor echocardiographic windows for analysis. Therefore, we ultimately analyzed 457 patients (mean age, 67 ± 11 years; 62% men). Baseline clinical and laboratory characteristics are presented in Table 1 . During follow-up (median, 20.5 months), 37 patients (8.1%) experienced cardiac events, nine patients died from cardiac causes, and 28 patients were hospitalized for treatment of HF decompensation. Regarding cardiac events, patients who experienced cardiac events were significantly older, had lower body mass indexes and body surface areas (lower body weights and heights), and had lower systolic and diastolic blood pressure. In addition, NYHA class was associated with a higher event rate. The majority of patients (about 97%) were distributed between NYHA classes II and III. The prevalence of a history of HF in the event group was significantly greater than in the no-event group, which may reflect more frequent use of diuretics in the event group.
Variable | Total ( n = 457) | No events ( n = 420) | Events ( n = 37) | P ∗ |
---|---|---|---|---|
Age (y) | 66.6 ± 10.9 | 66.2 ± 10.9 | 70.8 ± 9.5 | .013 |
Men | 283 (61.9%) | 263 (62.6%) | 20 (54.1%) | .377 |
BMI (kg/m 2 ) | 39.1 ± 6.1 | 39.3 ± 6.1 | 36.4 ± 5.5 | .006 |
BSA (m 2 ) | 1.67 ± 0.19 | 1.68 ± 0.20 | 1.57 ± 0.16 | .001 |
Heart rate (beats/min) | 82.5 ± 20.6 | 81.9 ± 20.3 | 89.7 ± 22.6 | .028 |
Systolic BP (mm Hg) | 124.2 ± 17.0 | 124.8 ± 17.1 | 116.8 ± 14.9 | .006 |
Diastolic BP (mm Hg) | 73.5 ± 11.8 | 73.9 ± 11.7 | 68.9 ± 12.0 | .015 |
NYHA class | <.001 | |||
II | 354 (78%) | 336 (80%) | 18 (49%) | |
III | 87 (19%) | 77 (18%) | 10 (27%) | |
IV | 16 (3%) | 7 (2%) | 9 (24%) | |
Medical history | ||||
Hypertension | 147 (32.2%) | 135 (32.1%) | 12 (32.4%) | 1.000 |
DM | 138 (30.2%) | 127 (30.2%) | 11 (29.7%) | 1.000 |
IHD | 92 (20.1%) | 81 (19.3%) | 11 (29.7%) | .136 |
Stroke | 81 (17.7%) | 76 (18.1%) | 5 (13.5%) | .654 |
CHF | 53 (11.6%) | 37 (8.8%) | 16 (43.2%) | <.001 |
Hemoglobin (g/dL) | 13.4 ± 2.0 | 13.5 ± 2.0 | 12.5 ± 1.8 | .003 |
Blood urea nitrogen (mg/dL) | 19.6 ± 11.5 | 19.3 ± 11.2 | 22.0 ± 13.7 | .184 |
Creatinine (mg/dL) | 1.1 ± 0.5 | 1.1 ± 0.5 | 1.2 ± 0.6 | .290 |
Uric acid (mg/dL) | 6.2 ± 1.8 | 6.1 ± 1.7 | 7.0 ± 2.1 | .051 |
Medications | ||||
Aspirin | 205 (44.9%) | 187 (44.5%) | 18 (48.6%) | .731 |
β-blockers | 193 (42.2%) | 174 (41.4%) | 19 (51.4%) | .159 |
Digoxin | 102 (22.3%) | 92 (21.9%) | 10 (27.0%) | .536 |
ACE inhibitors | 82 (17.9%) | 78 (18.6%) | 4 (10.8%) | .369 |
ARBs | 92 (20.1%) | 83 (19.8%) | 9 (24.3%) | .522 |
Diuretics | 172 (37.6%) | 144 (34.3%) | 28 (75.7%) | <.001 |
Anticoagulants | 142 (31.1%) | 127 (30.2%) | 15 (40.5%) | .199 |
Comparison of Echocardiographic Findings
Table 2 summarizes the conventional and tissue Doppler echocardiographic findings. The mean LV EF was 59 ± 9.9%, and the average ratio of peak early diastolic mitral inflow to annular velocity (E/e′) was 13 ± 6.7. There were no significant differences in RV dimension or LV wall thickness between patients with and without cardiac events. Patients who experienced cardiac events were more likely to have significantly lower EFs, larger LV end-systolic dimensions, higher pulmonary artery systolic pressure (PASP), and greater LA volume indexes or LA dimensions. With respect to DTI, patients displayed lower s′ and e′ velocities at both the septal and lateral MV annuli as well as the tricuspid annulus. They also had a higher averaged E/e′ ratios.
Variable | Total ( n = 457) | No events ( n = 420) | Events ( n = 37) | P ∗ |
---|---|---|---|---|
LVEDD (mm) | 50.1 ± 5.6 | 50.1 ± 5.5 | 50.7 ± 6.8 | .535 |
LVESD (mm) | 34.1 ± 6.6 | 33.9 ± 6.5 | 36.7 ± 8.0 | .012 |
LV EF (%) | 58.7 ± 9.9 | 59.5 ± 9.1 | 49.6 ± 13.5 | <.001 |
LAD (mm) | 49.8 ± 6.9 | 49.6 ± 6.9 | 51.9 ± 6.5 | .049 |
LAVI (mL/m 2 ) | 70.2 ± 22.4 | 69.2 ± 22.1 | 82.9 ± 23.7 | <.001 |
IVWT (mm) | 9.7 ± 1.7 | 9.7 ± 1.4 | 10.2 ± 3.6 | .362 |
PWT (mm) | 9.6 ± 1.4 | 9.6 ± 1.3 | 9.7 ± 2.0 | .791 |
RVD (mm) | 24.2 ± 5.1 | 24.1 ± 4.9 | 25.7 ± 6.7 | .163 |
Mitral inflow | ||||
E velocity (cm/sec) | 100.7 ± 35.5 | 100.0 ± 34.9 | 108.7 ± 41.6 | .155 |
DT (msec) | 202.0 ± 94.5 | 201.6 ± 90.9 | 206.7 ± 130.1 | .754 |
IRT (msec) | 95.7 ± 19.9 | 95.7 ± 19.9 | 95.6 ± 20.0 | .978 |
PASP (mm Hg) | 31.4 ± 10.9 | 30.7 ± 10.6 | 39.6 ± 12.3 | <.001 |
DTI | ||||
Tricuspid s′ (cm/sec) | 10.3 ± 2.28 | 10.5 ± 2.23 | 8.14 ± 1.66 | <.001 |
Tricuspid e′ (cm/sec) | 12.9 ± 3.29 | 13.2 ± 3.24 | 9.99 ± 2.26 | <.001 |
Septal s′ (cm/sec) | 5.97 ± 1.48 | 6.09 ± 1.46 | 4.56 ± 0.93 | <.001 |
Septal e′ (cm/sec) | 7.65 ± 2.11 | 7.85 ± 2.03 | 5.33 ± 1.42 | <.001 |
Lateral s′ (cm/sec) | 7.68 ± 2.18 | 7.79 ± 2.14 | 6.45 ± 2.35 | <.001 |
Lateral e′ (cm/sec) | 10.7 ± 3.14 | 10.9 ± 3.11 | 8.61 ± 2.75 | <.001 |
Average E/e′ ratio | 12.5 ± 6.72 | 12.1 ± 6.35 | 17.1 ± 8.99 | .002 |
Associations with Adverse Cardiac Events
In univariate Cox analyses, the hazard ratio for cardiac events increased with higher NYHA class, higher LA volume index, increased PASP, and lower tricuspid s′ and septal e′ ( Table 3 ). There were also weak associations between cardiac events and old age, decreased blood pressure, rapid heart rate, decreased hemoglobin level, increased RV dimension, and higher average E/e′ ratio (data not shown). In multivariate analyses, septal e′ velocity, tricuspid s′ velocity, and PASP remained significant predictors of cardiac events. In particular, when we divided the overall study population according to an EF of 55%, two thirds of study patients showed HF and AF with preserved EF (mean, 63%), and the rest had reduced EFs (mean, 45%). An additional analysis subclassifying patients into two categories of EF above or below 55% revealed that a significant association of risk for clinical outcomes was observed in both groups ( Figure 2 ). After adjustments for covariate, hazard ratios of tricuspid s′ and septal e′ in the lower EF group were attenuated from 0.49 to 0.69 and from 0.42 to 0.56, respectively.
Univariate | Multivariate | |||
---|---|---|---|---|
Variable | HR (95% CI) | P | HR (95%CI) | P |
Age | 1.045 (1.009–1.081) | .013 | 1.024 (0.985–1.065) | .223 |
NYHA class (III, IV) | 4.106 (2.656–6.348) | <.001 | 2.004 (0.942–4.263) | .071 |
LA volume index | 1.042 (1.010–1.038) | .001 | 1.008 (0.991–1.026) | .365 |
PASP | 1.059 (1.034–1.085) | <.001 | 1.030 (1.002–1.059) | .035 |
Tricuspid s′ | 0.532 (0.434–0.651) | <.001 | 0.622 (0.500–0.773) | <.001 |
Septal e′ | 0.374 (0.291–0.481) | <.001 | 0.529 (0.405–0.691) | <.001 |